SCHEMBL1634182

SCHEMBL1634182

NS(=O)(=O)c1ccc(Nc2ncc3cccc(Oc4ccccc4)c3n2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.60
CA2 P00918 5/20 0.60
CA9 Q16790 5/20 0.60
IKBKB O14920 8/20 0.57
DKK1 O94907 1/20 0.48
GSK3B P49841 1/20 0.48
CA12 O43570 3/20 0.48
CA4 P22748 1/20 0.47
CCNT1 O60563 2/20 0.46
CDK1 P06493 2/20 0.46
CCNB1 P14635 2/20 0.46
CDK7 P50613 2/20 0.46
CDK9 P50750 2/20 0.46
CCNH P51946 2/20 0.46
CDK2 P24941 1/20 0.46
AURKA O14965 1/20 0.46
AURKB Q96GD4 1/20 0.46
SOS1 Q07889 1/20 0.46
PLK1 P53350 1/20 0.45
STK4 Q13043 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633446 0.90 IKBKB (0.56) CA1CA2CA9IKBKBCA12
SCHEMBL1633814 0.88 EGFR (0.55) CA1CA2CA9IKBKBDKK1
SCHEMBL1632432 0.87 CYP1A2 (0.48) CA1CA2CA9IKBKBDKK1
SCHEMBL1634190 0.87 IKBKB (0.53) CA1CA2CA9IKBKBDKK1
SCHEMBL1633821 0.87 STK4 (0.52) CA1CA2CA9IKBKBCCNT1
SCHEMBL1633962 0.86 IKBKB (0.51) CA1CA2CA9IKBKBDKK1
SCHEMBL1633413 0.86 CA1 (0.47) CA1CA2CA9IKBKBDKK1
SCHEMBL1633262 0.84 IKBKB (0.49) CA1CA2CA9IKBKBDKK1
SCHEMBL1632825 0.84 IKBKB (0.48) CA1CA2CA9IKBKBDKK1
SCHEMBL1631365 0.82 IKBKB (0.46) CA1CA2CA9IKBKBCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed